-
4 weeks ago | 
bioprocessonline.com | Pooja Sharma |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: Minimizing your Risk in RNA-lipid Nanoparticle (LNP) Encapsulation and Drug Product Manufacturing Through a Holistic ApproachJoin us on March 31st to discover how Lonza's platform-based strategy ensures stability, efficacy, and quality in LNP Drug Products with nucleic acid payloads. Learn about critical process challenges in encapsulation, filtration, and aseptic filling, and how to proactively mitigate risks for successful GMP batch manufacturing.
-
1 month ago | 
bioprocessonline.com | Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino |Stephen Aiken
Webinar: Harnessing AI, Spatial Transcriptomics & Mass Spectrometry for Clinical InsightsThis webinar covers how preserving spatial molecular information enhances tissue analysis. It explores spatial-Omics platforms, AI models predicting treatment responses, and identifying patient subgroups. Topics include spatial-omics integration, AI-driven predictions, oncology applications, and improving molecular signatures for personalized medicine. Click here to learn more.
-
1 month ago | 
cellandgene.com | Ankitkumar Patel |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: Who’s In Charge of Your Trial? How to Ensure Effective Oversight and LeadershipClinical trials in complex therapeutic areas require more than just a solid strategy—they demand proactive and engaged operational leadership from the sponsor side. Join our expert panel to discuss how an active and knowledgeable Clin Ops lead, in collaboration with an experienced outsourcing project lead, can drive informed decision-making, enhance efficiency, and ultimately ensure trial success.
-
2 months ago | 
cellandgene.com | Elben Guimaraes |Xiaojun Liu |Junwei Sun |Lucia Fernandez |Lucia Fernández
Each approach has its advantages and drawbacks. This guide should help you decide which one, or perhaps a hybrid strategy, is best for your company. Exploring Strategies For Developing Robust AAV PlatformsExplore advanced AAV production platforms that enhance efficiency, scalability, and compliance, paving the way for safe and accessible gene therapies.
-
Jan 13, 2025 | 
cellandgene.com | Steve Kornher |Shanti Chari |Junwei Sun |Lucia Fernandez |Lucia Fernández
With over 450 unique products in clinical development and 50 anticipated approvals by 2030, the evolving regulatory landscape for cell and gene therapies is more critical than ever. Don't miss your chance to gain expert insights! Join the next Cell & Gene Live for an exclusive digital panel discussion exploring forward-looking perspectives on this transformative field. Registration is free—thanks to the support of Thermo Fisher Scientific.
-
Dec 10, 2024 | 
bioprocessonline.com | Antony Hitchcock |AGH Bioconsulting |Junwei Sun |Lucia Fernandez |Lucia Fernández
Let Us Handle Your Buffer PreparationThermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers.
-
Dec 10, 2024 | bioprocessonline.com | Antony Hitchcock |AGH Bioconsulting |Junwei Sun |Lucia Fernandez |Lucia Fernández
Let Us Handle Your Buffer PreparationThermo Fisher Scientific is here to support you with the buffer preparation in your manufacturing workflow. Leaving the non-core activities to us enables you to focus on the patient therapy development. Our capabilities cover off-the-shelf products like WFI, NaOH, NaCl, or EtOH, a library of the most frequently used buffers that are made-to-order, as well as fully customized buffers.
-
Dec 2, 2024 | 
bioprocessonline.com | Francisco Conesa Buendía |Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino
Webinar: mAb Up- and Downstream Process Intensification StrategiesJoin us on December 12 as we delve into techniques that streamline upstream and downstream production processes. Gain valuable insights on intensification of upstream performance by continuous perfusion including how a generation of ultra-high cell density banks enable reduction of N-1 process steps and costs. We will also share strategies to intensify the downstream purification process, both in affinity and polishing steps.
-
Nov 26, 2024 | 
bioprocessonline.com | Steve Erb |Andrea Rabellino |Junwei Sun |Lucia Fernandez |Lucia Fernández
Webinar: Early Preclinical Development of mRNA/LNP projects - Setting Up Your Project for a Successful Transition to cGMP ManufacturingJoin us on December 2nd to explore mRNA construct development at Lonza, focusing on cGMP manufacturing, analytical advancements, and testing methods. Gain insights into the transition from research to manufacturing and the technologies shaping mRNA development for future projects. Click here to learn more.
-
Nov 4, 2024 | 
cellandgene.com | Junwei Sun |Lucia Fernandez |Lucia Fernández |Matthew Ercolino |James Fasano
WuXi Advanced Therapies has recently published a 20+ page eBook on How-To Master Tech Transfer: Strategies To Sidestep Common Pitfalls.
